Serum fibroblast growth factor 19 is decreased in patients with overt hypothyroidism and subclinical hypothyroidism

As a newly emerging metabolic regulator, accumulating evidence suggests that the circulating fibroblast growth factor 19 (FGF19) level correlated with lipid and glucose metabolism. Several independent groups have found that FGF19 was highly likely associated with multiple metabolic disorders. Thyroi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medicine (Baltimore)
Hauptverfasser: Lai, Yaxin, Wang, Haoyu, Xia, Xinghai, Wang, Zhaojun, Fan, Chenling, Wang, Hong, Zhang, Hongmei, Ding, Shuangning, Teng, Weiping, Shan, Zhongyan
Format: Artigo
Sprache:Inglês
Veröffentlicht: Wolters Kluwer Health 2016
Schlagworte:
4300
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5265952/
https://ncbi.nlm.nih.gov/pubmed/27684859
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000005001
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge